참고문헌
- American Diabetes Association. (2010). Standards of medical care in diabetes-2010. Diabetes Care, 33(1), 11-69.
- Bektas F. E., Eray O., Sari R., Akbas H. (2004). Point of care blood ketone testing of diabetic patients in the emergency department, Endocr Res, 30, 395-402. https://doi.org/10.1081/ERC-200035231
- Canadian Diabetes Association. (2008). Clinical Practice Guideline Expert Committee. Hyperglycemic Emergencies in Adults. Canadian J Diabetes 32(1), 65-70.
- Chiu R. W. H., Ho C. S., Tong S. F., Ng K. F., Lam C. W. (2002). Evaluation of a new handheld biosensor for point-of-care testing of whole blood beta-hydroxybutyrate concentration, Hong Kong med J, 8, 172-176.
- Deeks JJ. (2011). Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323:157-162.
- Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977-986. https://doi.org/10.1056/NEJM199309303291401
- Guerci B., Benichou M., Floriot M., Bohme P., Fougnot S., Franck P., et al. (2003). Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients, Diabetes Care, 26, 1137-1141. https://doi.org/10.2337/diacare.26.4.1137
- Ham M. R. O., Okada P., White P. C. (2004). Bedside ketone determination in diabetic children with hyperglycemia and ketosis in the acute care setting, Pediatr Diabetes, 5, 39-43. https://doi.org/10.1111/j.1399-543X.2004.00032.x
- Health Insurance Review Agency. (2005). A Study on the Construction and Management of Health Technology Assessment System, Seoul: Health Insurance Review Agency, 227-228, in Korean.
- Higgins J. P. T., Green S. (2011). Cochrane handbook for systematic reviews of interventions 5.1.0(ed), United Kingdom: The Cochrane Collaboration, 33-49.
- International Diabetes Federation. Clinical Guideline Task Force. (2012). Global guide line for type 2 diabetes. Brussels: International Diabetes Federation. 32-100.
- Jung H. W., Park I. K. (2012). Evaluation of the Clinical Significance of Ketonuria, Lab Med Online, 2, 15-19. https://doi.org/10.3343/lmo.2012.2.1.3
- Khan KS, Kunz R, Kleijnen J, Antes G; Royal Society of Medi-cine (Great Britain). (2011). Systematic reviews to support evidence-based medicine: how to review and apply findings of health-care research. 2nd ed. London: Royal Society of Medicine; 2011. 201p.
- Kitabchi A. E., Umpierrez G. E., Miles J. M., Fisher J. N. (2009). Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 32, 1335-1343, 2009 https://doi.org/10.2337/dc09-9032
- Kitabchi A. E., Umpierrez G. E., Murphy M. B., Barrett E. J., Kreisberg R. A., Malone J. I. (2004). American Diabetes Association, Hyperglycemic crises in diabetes, Diabetes Care 27, 94-102. https://doi.org/10.2337/diacare.27.2007.S94
- Korea Centers for Disease Control and Prevention. (2011). Korea health statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1). Chungcheongbuk-do, Korea: Author.
- Ministry of Health and Welfare. (2011). Ministry of Health and Welfare Year Book 2011. Retrieved from http://stat.mw.go.kr/stat
- National Health Insurance Corporation. (2010). Health insurance statistical yearbook 2010. Retrieved from http://www.nhic.or.kr/portal/site/main/menuitem
- Neumann H. P. H. Pheochromocytoma. In: Longo D. L., Fauci A., Kasper D. L., Hauser S. L., Jameson J. L., Loscalzo J., editors. (2012). Harrison's principles of internal medicine, 18th ed, New York: McGraw-Hill, 2962-2967.
- PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analysis). (2013). Retrieved from http://www.prisma-statement.org/news.htm
- PRISMA Group. In: Moher D., Liberati A., Tetzlaff J., Altman D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 151, 264-269. https://doi.org/10.7326/0003-4819-151-4-200908180-00135
- Rewers A. M., McFann K., Chase H. P. (2006). Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children, Diabetes Technol Ther. 8, 671-676. https://doi.org/10.1089/dia.2006.8.671
- Samuelsson U., Ludvigsson J. (2002). When should determination of ketonemia be recommended?, Diabetes Technol Ther, 4, 645-650. https://doi.org/10.1089/152091502320798286
- Scottish Intercollegiate Guidelines Network. (2011). SIGN 50: a guideline developer's handbook. Scotland: NHS Quality Improvement, 52-92.
- UK Prospective Diabetes Study Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes [UKPDS 33]. Lancet, 352, 837-853. https://doi.org/10.1016/S0140-6736(98)07019-6
- Voulgari C., Tentolouris N. (2010). The performance of a glucose-ketone meter in the diagnosis of diabetic ketoacidosis in patients with type 2 diabetes in the emergency room, Diabetes Technol Ther, 12, 529-535. https://doi.org/10.1089/dia.2010.0011
- Yoong N. W. C. (2008). Blood ketone testing in the clinical laboratory - Technical evaluation of test-strips, Singapore General Hospital Proceedings, 17, 88-93.